股票 › NBIX
神经分泌生物科学 NBIX
美股市值排名 #1052
$164.63 +$4.87 (+3.05%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $164.63 0.00%
开盘$159.98
昨收$159.76
当日区间$158.66 – $165.86
成交量1.51M
市值$16.66B
市盈率（TTM）24.4
股息率–
财报
财报日平均波动±6.8%近16次财报
收涨次数8 / 1650% 的概率
最佳反应+8.9%
最差反应-18.5%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 30 Jul 2026 | After Market | ±8.1% | -10.08% | 超出定价预期 |
| 2026/Q1 | 5 May 2026 | After Market | ±7.4% | +8.86% | 超出定价预期 |
| 2025/Q4 | 11 Feb 2026 | After Market | ±6.7% | -10.43% | 超出定价预期 |
| 2025/Q3 | 28 Oct 2025 | After Market | ±8.9% | -6.35% | 符合区间 |
| 2025/Q2 | 30 Jul 2025 | After Market | ±9.2% | -6.24% | 符合区间 |
| 2025/Q1 | 5 May 2025 | After Market | ±12.4% | +8.36% | 符合区间 |
| 2024/Q4 | 6 Feb 2025 | After Market | ±7.8% | -18.53% | 超出定价预期 |
| 2024/Q3 | 30 Oct 2024 | Pre Market | ±8.1% | +7.01% | 符合区间 |
| 2024/Q2 | 1 Aug 2024 | Pre Market | ±16.3% | +8.18% | 符合区间 |
| 2024/Q1 | 1 May 2024 | Pre Market | ±7.3% | +3.99% | 符合区间 |
| 2023/Q4 | 7 Feb 2024 | Pre Market | ±7.1% | -4.67% | 符合区间 |
| 2023/Q3 | 31 Oct 2023 | Pre Market | ±9.5% | +3.56% | 符合区间 |
| 2023/Q2 | 1 Aug 2023 | Pre Market | ±7.5% | +1.52% | 符合区间 |
| 2023/Q1 | 3 May 2023 | Pre Market | ±7.8% | -4.67% | 符合区间 |
| 2022/Q4 | 6 Feb 2023 | Pre Market | ±8.4% | -4.55% | 符合区间 |
| 2022/Q3 | 1 Nov 2022 | After Market | ±12.7% | +2.26% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
营收构成
2026/Q2 季度
按业务线
基本面
最新报告季度：Q2, ended Jun 2026
营收$959.00M+39.5% YoY
营业利润$153.00M+5.1% YoY
净利润$144.40M+34.3% YoY
摊薄每股收益$1.39+31.1% YoY
自由现金流$128.60M+43.7% YoY
经营现金流$136.40M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率97.9%
营业利润率23.9%
净利率20.9%
净资产收益率22.1%
资产收益率15.3%
投入资本回报率19.5%
流动比率1.87
负债/资产比率31.1%
现金及投资$389.80M
总负债$401.80M
净现金（净负债）-$12.00M
自由现金流/营收25.8%
暂无评论——快来第一个聊聊 NBIX。